Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. by Mukhtyar, C, Flossmann, O, Hellmich, B, Bacon, P, Cid, M, Cohen-Tervaert, J, Gross, W, Guillevin, L, Jayne, D, Mahr, A, Merkel, P, Raspe, H, Scott, D, Witter, J, Yazici, H, Luqmani, R

“… OBJECTIVES: We undertook a systematic literature review as a background to the European League Against Rheumatism (EULAR) recommendations for conducting clinical trials in anti-neutrophil cytoplasm antibody associated vasculitis (AAV), and to assess the quality of evidence for outcome measures in AAV. …”

EULAR recommendations for the management of primary small and medium vessel vasculitis. by Mukhtyar, C, Guillevin, L, Cid, M, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C, Merkel, P, Raspe, H, Salvarani, C, Scott, D, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

“… OBJECTIVES: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. …”

EULAR recommendations for the management of large vessel vasculitis. by Mukhtyar, C, Guillevin, L, Cid, M, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C, Merkel, P, Raspe, H, Salvarani, C, Scott, D, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

“… OBJECTIVES: To develop European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis. …”

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts by Yates, M, Watts, R, Bajema, I, Cid, M, Crestani, B, Hauser, T, Hellmich, B, Holle, J, Laudien, M, Little, MA, Luqmani, RA, Mahr, A, Merkel, P, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, KWA, Vaglio, A, Yalçındağ, N, Jayne, DR, Mukhtyar, C

“…The European League Against Rheumatism recommendations for the management of antineutrophil cytoplasmic antibody-associated vasculitis have been recently published. …”

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. by Hellmich, B, Flossmann, O, Gross, W, Bacon, P, Cohen-Tervaert, J, Guillevin, L, Jayne, D, Mahr, A, Merkel, P, Raspe, H, Scott, D, Witter, J, Yazici, H, Luqmani, R

“… OBJECTIVES: To develop the European League Against Rheumatism (EULAR) recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis. …”

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). by Craven, A, Robson, J, Ponte, C, Grayson, P, Suppiah, R, Judge, A, Watts, R, Merkel, P, Luqmani, R

“…The study is following the guidelines for the development of classification criteria established by the American College of Rheumatology and the European League against Rheumatism. The study will incorporate the use of pre-defined cases of each condition to reduce the inherent circularity when developing new classification criteria and will explore alternative approaches to deriving reference standards by creating data-driven classification algorithms. …”

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. by Basu, N, Watts, R, Bajema, I, Baslund, B, Bley, T, Boers, M, Brogan, P, Calabrese, L, Cid, M, Cohen-Tervaert, J, Flores-Suarez, L, Fujimoto, S, de Groot, K, Guillevin, L, Hatemi, G, Hauser, T, Jayne, D, Jennette, C, Kallenberg, C, Kobayashi, S, Little, M, Mahr, A, McLaren, J, Merkel, P, Ozen, S

“…Consequently, a systematic literature review was undertaken looking to address these deficiencies and produce 'points to consider' in accordance with standardised European League Against Rheumatism (EULAR) operating procedures. …”